EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola survivors get vaccine shot in groundbreaking immunity study
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing how well Ebola survivors respond to the approved ERVEBO® vaccine compared to people receiving it for the first time. Researchers want to see if survivors get a strong, lasting immune boost from the vaccine, since their natural immunity can fade over time. Th…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE4 • Sponsor: Tulane University • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 04, 2026 15:30 UTC
-
Lifeline offered for ebola patients in outbreak zones
Disease control AVAILABLEThis program provides emergency access to an experimental three-antibody treatment called REGN-EB3 for people sick with Ebola virus disease. It is for patients in outbreak regions who are not eligible for the main clinical trials, including children and pregnant women. The goal i…
Matched conditions: EBOLA VIRUS DISEASE
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 19, 2026 14:59 UTC